SEMGLEE

This brand name is authorized in United States. It is also authorized in Australia, Croatia, Ecuador, Estonia, France, Ireland, Italy, Lithuania, New Zealand, Poland, Romania, Spain, UK.

Active ingredients

The drug SEMGLEE contains one active pharmaceutical ingredient (API):

1	Insulin glargine UNII 2ZM8CX04RZ - INSULIN GLARGINE
	Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH. After injection, the acidic solution is neutralised leading to formation of a precipitate from which small amounts of insulin glargine are continuously released.
	Read more about Insulin glargine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SEMGLEE Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10AE04	Insulin glargine	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting
Discover more medicines within A10AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11815W
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	179-MBE-0221, 237-MBE-1022
EE	Ravimiamet	1768091, 1768103, 1768114, 1793257
ES	Centro de información online de medicamentos de la AEMPS	1181270003
FR	Base de données publique des médicaments	60408661
GB	Medicines & Healthcare Products Regulatory Agency	360830, 391978
IT	Agenzia del Farmaco	046350017, 046350029, 046350031, 046350043, 046350056
LT	Valstybinė vaistų kontrolės tarnyba	1085343, 1085344, 1085345, 1088580, 1088581
NZ	Medicines and Medical Devices Safety Authority	20004
PL	Rejestru Produktów Leczniczych	100405550
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64292001, W64292002, W64292003
US	FDA, National Drug Code	49502-195, 49502-196